Xtx Topco LTD Compass Therapeutics, Inc. Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 20,221 shares of CMPX stock, worth $28,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,221

Holding current value

$28,713

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$0.8 - $1.88 $16,176 - $38,015	20,221 New	20,221 $37,000
Q2 2023 Aug 14, 2023	BUY	$2.64 - $3.48 $29,018 - $38,252	10,992 New	10,992 $34,000

Others Institutions Holding CMPX

# of Institutions

Shares Held

91.9M

Call Options Held

Put Options Held

Orbimed Advisors LLC San Diego, CA

22.4M
Shares

$31.8 Million
0.97% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

11.1M
Shares

$15.8 Million
0.04% of portfolio
Blackstone Inc New York, NY

10M
Shares

$14.2 Million
0.09% of portfolio
Black Rock Inc. New York, NY

6.61M
Shares

$9.39 Million
0.0% of portfolio
Bio Impact Capital LLC Cambridge, MA

5.64M
Shares

$8.01 Million
1.62% of portfolio

View Full List

About Compass Therapeutics, Inc.

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $144M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

More about CMPX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account